EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieKohortenstudieOpen Access · CC BY-NC 4.0

Clinical features and survival in Fibrosing Mediastinitis: a multicenter cohort study

Hanwen Zhang, Lingyan You, Beilan Yang, Qin Luo, Yinjiang Tang, Ting Wang, Gaxue Jiang, Qunying Xi, Yinli Wang, Hongyun Ruan, Jinglong Nan, Yicheng Yang und 12 weitere

Respiration · 2026

DOI: 10.1159/000550733 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Respiration, 2026. Verfasst von Hanwen Zhang und 23 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory and Pulmonary Vascular Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease…. Hauptthemen laut MEDLINE: Mediastinitis, Sclerosis. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Fibrosing mediastinitis (FM)—also known as mediastinal fibrosis or sclerosing mediastinitis—is a rare, benign, but potentially life-threatening disorder of unclear etiology. This study aimed to evaluate the clinical characteristics, geographic distribution, and long-term survival of patients with FM and to identify prognostic factors for all-cause mortality.

Methods

Of 215 patients screened, 192 were diagnosed with FM and included in the final cohort. The clinical characteristics and survival of patients with FM were reported. Prognostic factors were evaluated by Cox regression model.

Results

The mean age of FM patients was 66.6 ± 13.4 years. Geographic clustering was evident in northwestern China. Compared with survivors, deceased patients showed higher rates of edema (50.0% vs. 22.3%, P = 0.016), lower serum cholesterol (3.8 ± 0.8 mmol/L vs. 4.5 ± 1.1 mmol/L, P = 0.004), and elevated NT-proBNP (751.8 pg/mL vs. 220.5 pg/mL, P = 0.001). Echocardiography indicated more severe right ventricular remodeling in the deceased group. Chest CT commonly revealed bilateral mediastinal involvement (85.4%), lobar vascular compression, and mediastinal lymphadenopathy (88.5%). Over a median follow-up of 23 months, the 1-, 3-, and 5-year survival rates were 94.5%, 86.3%, and 84.6%, respectively. Right heart failure was the leading cause of death (50%). Multivariable Cox analysis identified smoking (HR 4.32, 95% CI 1.61–11.62, P = 0.004) and elevated systolic pulmonary artery pressure (sPAP) (HR 1.02 per mmHg, 95% CI 1.01–1.03, P = 0.017) as independent predictors of all-cause mortality. FM-related deaths were more strongly associated with current smoking (HR 15.18, P < 0.001), presence of pleural effusion (HR 5.10, P = 0.03), and elevated sPAP (HR 1.02 per mmHg, P = 0.011).

Conclusion

FM predominantly affects older adults and is geographically clustered in northwestern China. Smoking and elevated sPAP are key prognostic indicators for mortality. Despite substantial cardiopulmonary impairment, long-term survival remains relatively favorable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MediastinitisSclerosisAgedFemaleHumansMaleMiddle AgedChinaCholesterolCohort StudiesEchocardiographyEdemaNatriuretic Peptide, BrainPeptide FragmentsPrognosisProportional Hazards ModelsRetrospective StudiesSurvival RateTomography, X-Ray Computed

Stichwörter der Autor:innen

Clinical featuresFibrosing mediastinitisPulmonary hypertensionSurvival

Substanzen

CholesterolNatriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)

Autor:innen und Institutionen

  • Respiratory and Pulmonary Vascular Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical Colleg…
  • Yunnan Provincial Cardiovascular Disease Clinical Medical Center, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.
  • Inner Mongolia People's Hospital, Hohhot, China.
  • Cardiac Center, The First Hospital of Lanzhou University, Lanzhou, China.
  • Pulmonary Vascular Diseases General Ward, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, China.
  • The Third People's Hospital of Chengdu, Chengdu, China.

Zitieren

APA

Zhang, H., You, L., Yang, B., Luo, Q., Tang, Y., Wang, T., Jiang, G., Xi, Q., Wang, Y., Ruan, H., Nan, J., Yang, Y., Zeng, Q., Yan, W., Liu, B., Liang, Y., Zhao, Z., Yang, T., Chen, Y., …, & Xiong, C. (2026). Clinical features and survival in Fibrosing Mediastinitis: a multicenter cohort study. Respiration. https://doi.org/10.1159/000550733

Vancouver

Zhang H, You L, Yang B, Luo Q, Tang Y, Wang T, et al. Clinical features and survival in Fibrosing Mediastinitis: a multicenter cohort study. Respiration. 2026. doi:10.1159/000550733

BibTeX
@article{Zhang2026,
  author = {Zhang, Hanwen and You, Lingyan and Yang, Beilan and Luo, Qin and Tang, Yinjiang and Wang, Ting and Jiang, Gaxue and Xi, Qunying and Wang, Yinli and Ruan, Hongyun and Nan, Jinglong and Yang, Yicheng and Zeng, Qixian and Yan, Wenjie and Liu, Bingyang and Liang, Yanru and Zhao, Zhihui and Yang, Tao and Chen, Yu and Wu, Yan and Tao, Xincao and Zhou, Xiaoming and Liu, Zhihong and Xiong, Changming},
  title = {Clinical features and survival in Fibrosing Mediastinitis: a multicenter cohort study},
  journal = {Respiration},
  year = {2026},
  doi = {10.1159/000550733}
}
Kostenlos starten →